BROADWOOD PARTNERS L.P. 13D and 13G filings for Insight Molecular Diagnostics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-12 7:52 pm Purchase | 2026-02-10 | 13D | Insight Molecular Diagnostics Inc. IMDX | BROADWOOD PARTNERS L.P. | 12,082,089 37.400% | 521,739 (+4.51%) | Filing |
| 2025-02-10 8:46 pm Purchase | 2025-02-06 | 13D | Insight Molecular Diagnostics Inc. IMDX | BROADWOOD PARTNERS L.P. | 11,560,350 40.200% | 11,560,350 (New Position) | Filing |